Granules India Limited is pleased to announce that Mr. Ovais Sarmad has joined as an Advisor to the company. In this role, Mr. Sarmad will provide expert guidance on sustainability, climate policy, and environmental initiatives, helping to further Granules' commitment to integrating sustainability across its
This facility manufactures APIs & formulations of oncology and non-oncology products. Granules India Limited, announced that the Company’s Unit V facility located at Anakapally, Visakhapatnam, Andhra Pradesh, India has successfully completed the US Food and Drug Administration (FDA) inspection between 8th and 12th April 2024, resulting in zero
Granules India inaugurated and launched its packaging facility through its Granules Consumer Health (GCH) step-down subsidiary which is located in Manassas, Virginia, US. The facility is over 79,000 square feet and is equipped with packaging lines and clean rooms to package and ship prescription and
